https://www.marketscreener.com/quote/stock/MOONLAKE-IMMUNOTHERAPEUTI-136211572/news/MoonLake-announces-significant-improvements-with-Nanobody-sonelokimab-over-24-weeks-in-active-psor-46136500/?utm_source=telegram&utm_medium=social&utm_campaign=share